Q BioMed partners with Eversana on Strontium89

By AuntMinnie.com staff writers

November 8, 2021 -- Biotech company Q BioMed has partnered with life sciences firm Eversana to support the commercialization of its Strontium89 (strontium-89 chloride injection) therapeutic radiopharmaceutical in the U.S.

Q BioMed will use Eversana's full product commercialization model, which integrates services for market access, agency services, clinical and commercial field teams, health economics, and outcomes research and compliance.

Strontium89 is currently available in the U.S. for metastatic cancer bone pain palliation.

Copyright © 2021 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking